Nephrocalcinosis after kidney transplantation as a rare manifestation of parathyroid carcinoma
Authors:
I. Zahrádka 1; V. Petr 1; T. Roháľ 1; J. Malušková 2; C. Povýšil 3; O. Viklický 1
Authors‘ workplace:
Klinika nefrologie, Transplancentrum, Institut klinické a experimentální medicíny, Praha
1; Pracoviště klinické a transplantační patologie, Transplantcentrum, Institut klinické a experimentální medicíny, Praha
2; Ústav patologie 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice, Praha
3
Published in:
Klin. Biochem. Metab., 28, 2020, No. 1, p. 15-19
Overview
In our case report we present a case of parathyroid carcinoma in a kidney transplant recipient, which manifested as nephrocalcinosis of the kidney graft, diagnostic and treatment process of the patient. Even though hyperparathyroidism is very frequently encountered in patients with advanced kidney disease including kidney transplant recipients, a case of parathyroid carcinoma is extremely rare. In the commentary, diagnostic and therapeutic possibilities are discussed.
Keywords:
kidney transplantation – nephrocalcinosis – parathyroid neoplasms
Sources
1. Levin, A., Bakris, G. L., Molitch, M., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int., 2007, 71(1), p. 31-38.
2. Khan, M. W., Worcester, E. M., Straus, F. H., et al. Parathyroid carcinoma in secondary and tertiary hyperparathyroidism. J Am Coll Surg., 2004, 199(2), p. 312–319.
3. Wei, C. H., Harari, A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol., 2012, 13(1), p. 11–23.
4. Kunstman, J. W., Kirsch, J. D., Mahajan, A., et al. Clinical review: Parathyroid localization and implications for clinical management. J Clin Endocrinol Metab., 2013, 98(3), p. 902–912.
5. Givi, B., Shah, J. P. Parathyroid Carcinoma. Clin Oncol R Coll Radiol G B., 2010, 22(6), p. 498–507.
6. Khan, A. A., Hanley, D. A., Rizzoli, R., et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int., 2017, 28(1), p. 1–19.
7. Weber, A. L., Randolph, G., Aksoy, F. G. The thyroid and parathyroid glands. CT and MR imaging and correlation with pathology and clinical findings. Radiol Clin North Am., 2000, 38(5), p. 1105–1129.
8. Kemps, B., van Ufford, H. Q., Creyghton, W., et al. Brown tumors simulating metastases on FDG PET in a patient with parathyroid carcinoma. Eur J Nucl Med Mol Imaging., 2008, 35(4), p. 850.
9. Evangelista, L., Sorgato, N., Torresan, F., et al. FDG-PET/CT and parathyroid carcinoma: Review of literature and illustrative case series. World J Clin Oncol., 2011, 2(10), p. 348–354.
10. Wilhelm, S. M., Wang, T. S., Ruan, D. T., et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperpara-thyroidism. JAMA Surg., 2016, 151(10), p. 959–968.
11. Koea, J. B., Shaw, J. H. Parathyroid cancer: biology and management. Surg Oncol., 1999, 8(3), p. 155–165.
12. McClenaghan, F., Qureshi, Y. A. Parathyroid cancer. Gland Surg., 2015, 4(4), p. 329–38.
13. Witteles, R. Parathyroid carcinoma. In: Surgery of the thyroid and parathyroid glands. Philadelphia: Saunders, 2003, p. 578–590.
14. Long, K. L., Sippel, R. S. Current and future treatments for parathyroid carcinoma. Int J Endocr Oncol., 2018, 5(1), IJE06.
15. Vellanki, P., Lange, K., Elaraj, D., Kopp, P. A., El Muayed, M. Denosumab for management of parathyroid carcinoma-mediated hypercalcemia. J Clin Endocrinol Metab., 2014, 99(2), p. 387–390.
16. Julian, B. A., Quarles, L. D., Niemann, K. M. Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis Off J Natl Kidney Found., 1992, 19(2), p. 99–120.
17. Kim, B. S., Ryu, H. S., Kang, K. H., Park, S. J. Parathyroid carcinoma in tertiary hyperparathyroidism. Asian J Surg., 2016, 39(4), p. 255–259.
18. Wong, G., Chapman, J. R., Craig, J. C. Death from cancer: a sobering truth for patients with kidney transplants. Kidney Int., 2014, 85(6), p. 1262–1264.
Labels
Clinical biochemistry Nuclear medicine Nutritive therapistArticle was published in
Clinical Biochemistry and Metabolism
2020 Issue 1
Most read in this issue
- Doporučení: Systém externího hodnocení kvality (EHK)
- Doporučení České společnosti klinické biochemie k jednotkám výsledků měření
- Progressive familial intrahepatic cholestasis in adulthood: 60 years’ follow-up
- Doporučení České společnosti klinické biochemie a České myelomové skupiny k laboratorní diagnostice monoklonálních gamapatií